Importance of receptor-mediated endocytosis in peptide delivery and targeting: Kinetic aspects

Advanced Drug Delivery Reviews

Volumn 19, Issue 3, 1996, Pages 445-467

  Sato, Hitoshi ^a   Sugiyama, Yuichi ^b   Tsuji, Akira ^c   Horikoshi, Isamu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

Peptide delivery and targeting; Receptor recycling; Receptor mediated endocytosis (RME)

Indexed keywords

CELLS; DRUG DOSAGE; ESTIMATION; MATHEMATICAL MODELS; PHARMACOKINETICS; POLYPEPTIDES; REACTION KINETICS;

RECEPTOR MEDIATED ENDOCYTOSIS; RECEPTOR RECYCLING; TARGETING;

CONTROLLED DRUG DELIVERY;

ADEFOVIR; ANTINEOPLASTIC AGENT; ASIALOFETUIN; ASIALOGLYCOPROTEIN; ASIALOOROSOMUCOID; ATRIAL NATRIURETIC FACTOR; BOVINE SERUM ALBUMIN; CYTARABINE; DEXTRAN; DOXORUBICIN; GLYCOPROTEIN; HORSERADISH PEROXIDASE; INSULIN; LOW DENSITY LIPOPROTEIN; LYSOZYME; MEMBRANE RECEPTOR; METHOTREXATE; NAPROXEN; PEPTIDE DERIVATIVE; POLYLYSINE; POLYPEPTIDE; RECEPTOR; SUPEROXIDE DISMUTASE; TRANSFERRIN; UNINDEXED DRUG; ZIDOVUDINE;

DRUG CLEARANCE; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TARGETING; ENDOCYTOSIS; HUMAN; INTERNALIZATION; KINETICS; MODEL; NONHUMAN; PHARMACEUTICS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW;

EID: 0030580944     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-409X(96)00013-0     Document Type: Review

References (187)

1. [1] Stahl, P. and Schwartz, A.L. (1986) Receptor-mediated endocytosis. J. Clin. Invest. 77, 657-662.
2. [2] Wileman, T., Harding, C. and Stahl, P. (1985) Receptor-mediated endocytosis. Biochem. J. 232, 1-14.
3. [3] Goldstein, J.L., Brown, M.S., Anderson, R.G., Russell, D.W. and Schneider, W.J. (1985) Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Ann. Rev. Cell Biol. 1, 1-39.
4. [4] Carpentier, J.L. (1984) Receptor-mediated endocytosis of polypeptide hormones: mechanism and significance. Mol. Immunol. 21, 1157-1159.
5. [5] Pastan, I.H. and Willingham, M.C. (1981) Journey to the center of the cell: role of the receptosome. Science 214, 504-509.
6. [6] Gorden, P., Carpentier, J.L., Freychet, P.O. and Orci, L. (1980) Internalization of polypeptide hormones: mechanism, intracellular localization and significance. Diabetologia 18, 263-274.
7. [7] Brown, M.S. and Goldstein, J.L. (1979) Receptor-mediated endocytosis: insights from the lipoprotein receptor system. Proc. Natl. Acad. Sci. U.S.A. 76, 3330-3337.
8. [8] Goldstein, J.L., Anderson, R.G. and Brown, M.S. (1979) Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature 279, 679-685.
9. [9] Olsnes, S., Kozlov, J.V., van Deurs, B. and Sandvig, K. (1991) Bacterial protein toxins acting on intracellular targets. Sem. Cell Biol. 2, 7-14.
10. [10] FitzGerald, D. and Pastan, I. (1991) Redirecting Pseudomonas exotoxin. Sem. Cell Biol. 2, 31-37.
11. [11] Carrasco, L. (1994) Entry of animal viruses and macromolecules into cells. FEBS Lett. 350, 151-154.
12. [12] Pauza, C.D. (1991) The endocytic pathway for human immunodeficiency virus infection. Adv. Exp. Med. Biol. 300, 111-138.
13. [13] Sugiyama, Y. and Kato, Y. (1994) Pharmacokinetic aspects of peptide delivery and targeting: importance of receptor-mediated endocytosis. Drug Develop. Ind. Pharm. 20, 591-614.
14. [14] Pardridge, W.M. (1992) Recent developments in peptide drug delivery to the brain. Pharmacol. Toxicol. 71, 3-10.
15. [15] Basu, S.K. (1990) Receptor-mediated endocytosis of macromolecular conjugates in selective drug delivery. Biochem. Pharmacol. 40, 1941-1946.
16. [16] Meijer, D.K. and van der Sluijs, P. (1989) Covalent and noncovalent protein binding of drugs: implications for hepatic clearance, storage, and cell-specific drug delivery. Pharm. Res. 6, 105-118.
17. [17] Fiume, L., Busi, C., Mattioli, A. and Spinosa, G. (1988) Targeting of antiviral drugs bound to protein carriers. Crit. Rev. Ther. Drug Carrier Sys. 4, 265-284.
18. [18] Dragsten, P.R., Mitchell, D.B., Covert, G. and Baker, T. (1987) Drug delivery using vesicles targeted to the hepatic asialoglycoprotein receptor. Biochim. Biophys. Acta 926, 270-279.
19. [19] Fallon, R.J. and Schwartz, A.L. (1985) Receptor-mediated endocytosis and targeted drug delivery. Hepatology 5, 899-901.
20. [20] Fiume, L., Busi, C. and Mattioli, A. (1983) Targeting of antiviral drugs by coupling with protein carriers. FEBS Lett. 153, 6-10.
21. [21] Pastan, I. and FitzGerald, D. (1991) Recombinant toxins for cancer treatment. Science 254, 1173-1177.
22. [22] Pastan, I. and FitzGerald, D. (1989) Pseudomonas exotoxin: chimeric toxins. J. Biol. Chem. 264, 15157-15160.
23. [23] Ciechanover, A., Schwartz, A.L., Dautry-Varsat, A. and Lodish, H.F. (1983) Kinetics of internalization and recycling of transferrin and the transferrin receptor in a human hepatoma cell line. Effect of lysosomotropic agents. J. Biol. Chem. 258, 9681-9689.
24. [24] Klausner, R.D., Ashwell, G., van Renswoude, J., Harford, J.B. and Bridges, K.R. (1983) Binding of apotransferrin to K562 cells: explanation of the transferrin cycle. Proc. Natl. Acad. Sci. U.S.A. 80, 2263-2266.
25. [25] Dautry-Varsat, A., Ciechanover, A. and Lodish, H.F. (1983) pH and the recycling of transferrin during receptor-mediated endocytosis. Proc. Natl. Acad. Sci. U.S.A. 80, 2258-2262.
26. [26] Hopkins, C.R. and Trowbridge, I.S. (1983) Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells. J. Cell Biol. 97, 508-521.
27. [27] Dan, N. and Cutler, D.F. (1994) Transcytosis and processing of intrinsic factor-cobalamin in Caco-2 cells. J. Biol. Chem. 269, 18849-18855.
28. [28] Ghinea, N., Mai, T.V., Groyer-Picard, M.T. and Milgrom, E. (1994) How protein hormones reach their target cells. Receptor-mediated transcytosis of hCG through endothelial cells. J. Cell Biol. 125, 87-97.
29. [29] Magnusson, S., Faerevik, I. and Berg, T. (1992) Characterization of retroendocytosis in rat liver parenchymal cells and sinusoidal endothelial cells. Biochem. J. 287, 241-246.
30. [30] Maratos-Flier, E., Kao, C.Y., Verdin, E.M. and King, G.L. (1987) Receptor-mediated vectorial transcytosis of epidermal growth factor by Madin-Darby canine kidney cells. J. Cell Biol. 105, 1595-1601.
31. [31] Fukuta, M., Okada, H., Iinuma, S., Yanai, S. and Toguchi, H. (1994) Insulin fragments as a carrier for peptide delivery across the blood-brain barrier. Pharm. Res. 11, 1681-1688.
32. [32] Bickel, U., Yoshikawa, T., Landaw, E.M., Faull, K.F. and Pardridge, W.M. (1993) Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery. Proc. Natl. Acad. Sci. U.S.A. 90, 2618-2622.
33. [33] Pardridge, W.M., Kumagai, A.K. and Eisenberg, J.B. (1987) Chimeric peptides as a vehicle for peptide pharmaceutical delivery through the blood-brain barrier. Biochem. Biophys. Res. Commun. 146, 307-313.
34. [34] Akhlynina, T.V., Rosenkranz, A.A., Jans, D.A. and Sobolev, A.S. (1995) Insulin-mediated intracellular targeting enhances the photodynamic activity of chlorin e6. Cancer Res. 55, 1014-1019.
35. [35] Moroianu, J. and Riordan, J.F. (1994) Nuclear translocation of angiogenic proteins in endothelial cells: an essential step in angiogenesis. Biochemistry 33, 12535-12539.
36. [36] Laduron, P.M. (1994) From receptor internalization to nuclear translocation. New targets for long-term pharmacology. Biochem. Pharmacol. 47, 3-13.
37. [37] Rosenkranz, A.A., Yachmenev, S.V., Jans, D.A., Serebryakova, N.V., Murav'ev, V.I., Peters, R. and Sobolev, A.S. (1992) Receptor-mediated endocytosis and nuclear transport of a transfecting DNA construct. Exp. Cell Res. 199, 323-329.
38. [38] Moroianu, J. and Riordan, J.F. (1994) Identification of the nucleolar targeting signal of human angiogenin. Biochem. Biophys. Res. Commun. 203, 1765-1772.
39. [39] Plank, C., Oberhauser, B., Mechtler, K., Koch, C. and Wagner, E. (1994) The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J. Biol. Chem. 269, 12918-12924.
40. [40] Friedmann, T. (1994) Gene therapy for neurological disorders. Trends Genet. 10, 210-214.
41. [41] Roemer, K. and Friedmann, T. (1992) Concepts and strategies for human gene therapy. Eur. J. Biochem. 208, 211-225.
42. [42] Friedmann, T. (1989) Progress toward human gene therapy. Science 244, 1275-1281.
43. [43] Huckett, B., Ariatti, M. and Hawtrey, A.O. (1990) Evidence for targeted gene transfer by receptor-mediated endocytosis. Stable expression following insulin-directed entry of NEO into HepG2 cells. Biochem. Pharmacol. 40, 253-263.
44. [44] McMartin, C. (1989) Molecular sieving, receptor processing and peptidolysis as major determinants of peptide pharmacokinetics in vivo. Biochem. Soc. Trans. 17, 931-934.
45. [45] Bennett, H.P. and McMartin, C. (1978) Peptide hormones and their analogues: distribution, clearance from the circulation, and inactivation in vivo. Pharmacol. Rev. 30, 247-292.
46. [46] Gerlowski, L.E. and Jain, R.K. (1983) Physiologically based pharmacokinetic modeling: principles and applications. J. Pharm. Sci. 72, 1103-1127.
47. [47] Lin, J.H., Sugiyama, Y., Awazu, S. and Hanano, M. (1982) Physiological pharmacokinetics of ethoxybenzamide based on biochemical data obtained in vitro as well as on physiological data. J. Pharm. Sci. 10, 649-661.
48. [48] Tsuji, A., Yoshikawa, T., Nishide, K., Minami, H., Kimura, M., Nakashima, E., Terasaki, T., Miyamoto, E., Nightingale, C.H. and Yamana, T. (1983) Physiologically based pharmacokinetic model for β-lactam antibiotics I: Tissue distribution and elimination in rats. J. Pharm. Sci. 72, 1239-1252.
49. [49] Bischoff, K.B. and Dedrick, R.L. (1968) Thiopental pharmacokinetics. J. Pharm. Sci. 57, 1346-1351.
50. [50] Baxter, L.T., Zhu, H., Mackensen, D.G. and Jain, R.K. (1994) Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice. Cancer Res. 54, 1517-1528.
51. [51] Sato, H., Sugiyama, Y., Sawada, Y., Iga, T. and Hanano, M. (1987) Physiologically based pharmacokinetics of radioiodinated human β-endorphin in rats. An application of the capillary membrane-limited model. Drug Metab. Dispos. 15, 540-550.
52. [52] Covell, D.G., Barbet, J., Holton, O.D., Black, C.D.V., Parker, R.J. and Weinstein, J.N. (1986) Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice. Cancer Res. 46, 3969-3978.
53. [53] Sato, H., Sugiyama, Y., Sawada, Y., Iga, T. and Hanano, M. (1985) Binding of radioiodinated human β-endorphin to serum proteins from rats and humans, determined by several methods. Life Sci. 37, 1309-1318.
54. 2-macroglobulin and the binding is inhibited by heparin. J. Biol. Chem. 268, 7685-7691.
55. 2-macroglobulin-methylamine. Am. J. Pathol. 138, 265.
56. 2-macroglobulin. J. Biol. Chem. 264, 5818.
57. 2-Macroglobulin is a binding protein for basic fibroblast growth factor. J. Biol. Chem. 264, 7210-7216.
58. 2-macroglobulin. Proc. Natl. Acad. Sci. U.S.A. 81, 342.
59. [59] Lantz, M., Thysell, H., Nilsson, E. and Olsson, I. (1991) On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin. J. Clin. Invest. 88, 2026-2031.
60. [60] Copeland, R.A., Ji, H., Halfpenny, A.J., Williams, R.W., Thompson, K.C., Herber, W.K., Thomas, K.A., Bruner, M.W., Ryan, J.A., Marquis-Omer, D. et al. (1991) The structure of human acidic fibroblast growth factor and its interaction with heparin. Arch. Biochem. Biophys. 289, 53-61.
61. [61] Baird, A., Schubert, D., Ling, N. and Guillemin, R. (1988) Receptor-and heparin-binding domains of basic fibroblast growth factor. Proc. Natl. Acad. Sci. U.S.A. 85, 2324-2328.
62. [62] Ader, M. and Bergman, R.N. (1994) Importance of transcapillary insulin transport to dynamics of insulin action after intravenous glucose. Am. J. Physiol. 266, E17-E25.
63. [63] Sung, C., Youle, R.J. and Dedrick, R.L. (1990) Pharmacokinetic analysis of immunotoxin uptake in solid tumors: role of plasma kinetics, capillary permeability, and binding. Cancer Res. 50, 7382-7392.
64. [64] Yang, Y.J., Hope, I.D., Ader, M. and Bergman, R.N. (1989) Insulin transport across capillaries is rate limiting for insulin action in dogs. J. Clin. Invest. 84, 1620-1628.
65. [65] Rasio, E. (1982) The capillary barrier to circulating insulin. Diabetes Care 5, 158-161.
66. [66] Jain, R.K. (1989) Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J. Natl. Cancer Inst. 81, 570-576.
67. [67] Jain, R.K. (1987) Transport of molecules in the tumor interstitium: a review. Cancer Res. 47, 3039-3051.
68. [68] Juweid, M., Neumann, R., Paik, C., Perez-Bacete, M.J., Sato, J., van Osdol, W. and Weinstein, J.N. (1992) Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. Cancer Res. 52, 5144-5153.
69. [69] Weinstein, J.N. and van Osdol, W. (1992) Early intervention in cancer using monoclonal antibodies and other biological ligands: micropharmacology and the "binding site barrier". Cancer Res. 52, 2747s-2751s.
70. [70] Fujimori, K., Fisher, D.R. and Weinstein, J.N. (1991) Integrated microscopic-macroscopic pharmacology of monoclonal antibody radioconjugates: the radiation dose distribution. Cancer Res. 51, 4821-4827.
71. [71] Kuwabara, T., Kato, Y., Kobayashi, S., Suzuki, H. and Sugiyama, Y. (1994) Nonlinear pharmacokinetics of a recombinant human granulocyte colony-stimulating factor derivative (nartograstim): species differences among rats, monkeys and humans. J. Pharmacol. Exp. Ther. 271, 1535-1543.
72. [72] Abassi, Z.A., Tate, J., Hunsberger, S., Klein, H., Trachewsky, D. and Keiser, H.R. (1992) Pharmacokinetics of ANF and urodilatin during cANF receptor blockade and neutral endopeptidase inhibition. Am. J. Physiol. 263, E870-E876.
73. 125I-atrial natriuretic factor in anaesthetized rats. Effects of neutral endopeptidase inhibition with candoxatrilat and of ANF-C receptor blockade. Biochem. Pharmacol. 44, 1013-1022.
74. [74] Chiu, P.J., Tetzloff, G., Romano, M.T., Foster, C.J. and Sybertz, E.J. (1991) Influence of C-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats. Am. J. Physiol. 260, R208-R216.
75. [75] Kiyokawa, H., Kono, N., Hamaguchi, T., Kawachi, M., Tajima, K., Yamada, Y., Hara, N., Mineo, I., Kuwajima, M. and Tarui, S. (1989) Autoantibodies to the insulin receptor impair clearance of plasma endogenous insulin. Diab. Res. Clin. Prac. 7, S41-S44.
76. [76] Stevenson, R.W., Cherrington, A.D. and Steiner, K.E. (1985) The relationship between plasma concentration and disappearance rate of immunoreactive insulin in the conscious dog. Horm. Metab. Res. 17, 551-553.
77. [77] Eaton, R.P., Friedman, N., Allen, R.C. and Schade, D.S. (1984) Insulin removal in man: in vivo evidence for a receptor-mediated process. J. Clin. Endocrinol. Metab. 69, 555-559.
78. [78] Weitzman, R.E. and Fisher, D.A. (1978) Arginine vasopressin metabolism in dogs. I. Evidence for a receptor-mediated mechanism. Am. J. Physiol. 235, E591-E597.
79. [79] Nussenzveig, D.R., Lewicki, J.A. and Maack, T. (1990) Cellular mechanisms of the clearance function of type C receptors of atrial natriuretic factor. J. Biol. Chem. 265, 20952-20958.
80. [80] Okolicany, J., McEnroe, G.A., Koh, G.Y., Lewicki, J.A. and Maack, T. (1992) Clearance receptor and neutral endopeptidase-mediated metabolism of atrial natriuretic factor. Am. J. Physiol. 263, F546-F553.
81. [81] Zeleznik, A.J. and Roth, J. (1978) Demonstration of the insulin receptor in vivo in rabbits and its possible role as a reservoir for the plasma hormone. J. Clin. Invest. 61, 1363-1374.
82. 3H]dynorphin (1-13) in the perfused rat lung: an application of the multiple-indicator dilution method. J. Pharm. Pharmacol. 42, 879-882.
83. [83] Sato, H., Sugiyama, Y., Sawada, Y., Iga, T., Sakamoto, S., Fuwa, T. and Hanano, M. (1988) Dynamic determination of kinetic parameters for the interaction between polypeptide hormones and cell-surface receptors in the perfused rat liver by the multiple-indicator dilution method. Proc. Natl. Acad. Sci. U.S.A. 85, 8355-8359.
84. [84] Kim, D.C., Sugiyama, Y., Satoh, H., Fuwa, T., Iga, T. and Hanano, M. (1988) Kinetic analysis of in vivo receptor-dependent binding of human epidermal growth factor by rat tissues. J. Pharm. Sci. 77, 200-207.
85. [85] Sato, H., Sugiyama, Y., Sawada, Y., Iga, T. and Hanano, M. (1988) In vivo evidence for the specific binding of human β-endorphin to the lung and liver of the rat. Biochem. Pharmacol. 37, 2273-2278.
86. [86] Whitcomb, D.C., O'Dorisio, T.M., Cataland, S., Shetzline, M.A. and Nishikawara, M.T. (1985) Identification of tissue insulin receptors: use of a unique in vivo radioreceptor assay. Am. J. Physiol. 249, E561-E567.
87. [87] Sato, H., Terasaki, T., Okumura, K. and Tsuji, A. (1991) Effect of receptor up-regulation on insulin pharmacokinetics in streptozotocin-treated diabetic rats. Pharm. Res. 8, 563-569.
88. [88] Yanai, S., Sugiyama, Y., Iga, T., Fuwa, T. and Hanano, M. (1990) Kinetic analysis of the downregulation of epidermal growth factor receptors in rats in vivo. Am. J. Physiol. 258, C593-C598.
89. [89] Sato, H., Sugiyama, Y., Kim, D.C., Yanai, S., Kurita, M., Fuwa, T., Iga, T. and Hanano, M. (1989) Decrease in the number of receptors for epidermal growth factor in the liver of D-galactosamine-intoxicated rats. Biochem. Pharmacol. 38, 2663-2671.
90. [90] Wong, M.W. and Jamieson, J.C. (1979) Evidence for reduced uptake of asialo-α1-acid glycoprotein during the acute phase response to inflammation. Life Sci. 25, 827-834.
91. [91] Stasi, R., Zinzani, L., Galieni, P., Lauta, V.M., Damasio, E., Dispensa, E., Dammacco, F., Venditti, A., Del Poeta, G., Cantonetti, M. et al. (1995) Clinical implications of cytokine and soluble receptor measurements in patients with newly-diagnosed aggressive non-Hodgkin's lymphoma. Eur. J. Haematol. 54, 9-17.
92. [92] Klein, B. and Brailly, H. (1995) Cytokine-binding proteins: stimulating antagonists. Immunol. Today 16, 216-220.
93. [93] Debets, R. and Savelkoul, H.F. (1994) Cytokine antagonists and their potential therapeutic use. Immunol. Today 15, 455-458.
94. [94] Mohler, K.M., Torrance, D.S., Smith, C.A., Goodwin, R.G., Stremler, K.E., Fung, V.P., Madani, H. and Widmer, M.B. (1993) Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 151, 1548-1561.
95. [95] Beguin, Y. (1992) The soluble transferrin receptor: biological aspects and clinical usefulness as quantitative measure of erythropoiesis. Haematologica 77, 1-10.
96. [96] Campbell, P.G. and Novak, J.F. (1991) Insulin-like growth factor binding protein (IGFBP) inhibits IGF action on human osteosarcoma cells. J. Cell. Physiol. 149, 293-300.
97. [97] Sugiyama, Y. and Kato, Y. (1995) In vitro models of hepatic clearance: Methods to determine the kinetic parameters for receptor-mediated hepatic uptake. In: M.D. Taylor and G.L. Amidon (Eds.), Peptide Based Drug Design: Controlling Transport and Metabolism, ACS Professional Reference Books, Washington, DC, pp. 525-551.
98. [98] Sugiyama, Y., Kim, D.-C., Satoh, H., Yanai, S., Sato, H., Iga, T. and Hanano, M. (1990) Receptor-mediated disposition of polypeptides: Kinetic analysis of the transport of epidermal growth factor as a model peptide using in vitro isolated perfused organs and in vivo system. J. Control. Rel. 13, 157-174.
99. [99] Sugiyama, Y. and Hanano, M. (1989) Receptor-mediated transport of peptide hormones and its importance in the overall hormone disposition in the body. Pharm. Res. 6, 192-202.
100. [100] Fallon, R.J. and Schwartz, A.L. (1989) Receptor-mediated delivery of drugs to hepatocytes. Adv. Drug Delivery Rev. 4, 49-63.
101. [101] Kongo, Y., Kondo, H., Kato, J., Sasaki, K., Tsushima, N., Nishisato, T., Hirayama, M., Fujikawa, K., Shintani, N., Mogi, Y. et al. (1990) Kinetics of internalization and cytotoxicity of transferrin-neocarzinostatin conjugate in human leukemia cell line, K562. Jpn. J. Cancer Res. 81, 91-99.
102. [102] Stoscheck, C.M. and Carpenter, G. (1984) Down regulation of epidermal growth factor receptors: direct demonstration of receptor degradation in human fibroblasts. J. Cell Biol. 98, 1048-1053.
103. [103] Korc, M. and Finman, J.E. (1989) Attenuated processing of epidermal growth factor in the face of marked degradation of transforming growth factor-α. J. Biol. Chem. 264, 14990-14999.
104. [104] Chen, M., Berman, J.R., MaCarroll, M.C. and Chen, I.W. (1981) Method for rapidly estimating specific radioactivity and radiochemical purity of radioiodinated peptide hormones used in radioimmunoassays. Clin. Chem. 27, 632-633.
105. 125I-labeled insulin in mice. Diabetes 39, 563-569.
106. 125I-insulin in human fibroblasts by the use of high performance liquid chromatography. Diabetes 32, 474-477.
107. [107] Besser, G.M., Orth, D.N., Nicholson, W.E., Byyny, R.L., Abe, K. and Woodham, J.P. (1971) Dissociation of the disappearance of bioactive and radioimmunoreactive ACTH from plasma in man. J. Clin. Endocrinol. Metab. 32, 595-603.
108. [108] Cockram, C.S., Jones, R.H., Boroujerdi, M.A. and Sonksen, P.H. (1984) Evidence for separate handling in vivo of different regions of the insulin molecule using A14-and B1-labeled insulin tracers. Diabetes 33, 721-727.
109. [109] Berman, M., McGuire, E.A., Roth, J. and Zeleznik, A.J. (1980) Kinetic modeling of insulin binding to receptors and degradation in vivo in the rabbit. Diabetes 29, 50-59.
110. [110] Wiley, H.S. and Cunningham, D.D. (1982) The endocytotic rate constant. A cellular parameter for quantitating receptor-mediated endocytosis. J. Biol. Chem. 257, 4222-4229.
111. [111] Wiley, H.S. and Cunningham, D.D. (1981) A steady state model for analyzing the cellular binding, internalization and degradation of polypeptide ligands. Cell 25, 433-440.
112. [112] Gex-Fabry, M. and DeLisi, C. (1986) Regulation of interacting populations during endocytosis: models of growth factor-tumor promoter dynamics. Am. J. Physiol. 250, R1123-R1132.
113. [113] Gex-Fabry, M. and DeLisi, C. (1984) Receptor-mediated endocytosis: a model and its implications for experimental analysis. Am. J. Physiol. 247, R768-R779.
114. [114] Kato, Y., Sato, H., Ichikawa, M., Suzuki, H., Sawada, Y., Hanano, M., Fuwa, T. and Sugiyama, Y. (1992) Existence of two pathways for the endocytosis of epidermal growth factor by rat liver: phenylarsine oxide-sensitive and -insensitive pathways. Proc. Natl. Acad. Sci. U.S.A. 89, 8507-8511.
115. [115] Yanai, S., Sugiyama, Y., Iga, T., Fuwa, T. and Hanano, M. (1991) Comparison of the methods for determining cell-surface and intracellular receptors for epidermal growth factor in the rat liver. Pharm. Res. 8, 557-562.
116. [116] Jackle, S., Runquist, E.A., Miranda-Brady, S. and Havel, R.J. (1991) Trafficking of the epidermal growth factor receptor and transferrin in three hepatocytic endosomal fractions. J. Biol. Chem. 266, 1396-1402.
117. [117] Rush, G.F. and Alberts, D. (1987) The hepatic binding and uptake kinetics of epidermal growth factor: studies with isolated rat hepatocytes. Life Sci. 40, 679-685.
118. [118] Dunn, W.A., Connolly, T.P. and Hubbard, A.L. (1986) Receptor-mediated endocytosis of epidermal growth factor by rat hepatocytes: receptor pathway. J. Cell Biol. 102, 24-36.
119. [119] Sato, H., Sugiyama, Y., Sawada, Y., Iga, T., Fuwa, T. and Hanano, M. (1990) Internalization of EGF in perfused rat liver is independent of the degree of receptor occupancy. Am. J. Physiol. 258, G682-G689.
120. [120] Dunn, W.A. and Hubbard, A.L. (1984) Receptor-mediated endocytosis of epidermal growth factor by hepatocytes in the perfused rat liver: ligand and receptor dynamics. J. Cell Biol. 98, 2148-2159.
121. [121] Wardzala, L.J., Simpson, I.A., Rechler, M.M. and Cushman, S.W. (1984) Potential mechanism of the stimulatory action of insulin on insulin-like growth factor II binding to the isolated rat adipose cell. Apparent redistribution of receptors cycling between a large intracellular pool and the plasma membrane. J. Biol. Chem. 259, 8378-8383.
122. [122] Draznin, B., Trowbridge, M. and Ferguson, L. (1984) Quantitative studies of the rate of insulin internalization in isolated rat hepatocytes. Biochem. J. 218, 307-312.
123. [123] Goresky, C.A. (1983) Kinetic interpretation of hepatic multiple-indicator dilution studies. Am. J. Physiol. 245, G1-G12.
124. [124] Goresky, C.A., Bach, G.C. and Nadeau, B.E. (1973) On the uptake of materials by the intact liver. The transport and net removal of galactose. J. Clin. Invest. 52, 991-1009.
125. [125] Whiteside, C.I., Lumsden, C.J. and Silverman, M. (1988) In vivo characterization of insulin uptake by dog renal cortical epithelium. Am. J. Physiol. 255, E357-E365.
126. [126] Zeleznik, A.J. and Roth, J. (1978) Demonstration of the insulin receptor in vivo in rabbits and its possible role as a reservoir for the plasma hormone. J. Clin. Invest. 61, 1363-1374.
127. [127] Yanai, S., Sugiyama, Y., Kim, D.C., Iga, T., Fuwa, T. and Hanano, M. (1991) Kinetic analysis of receptor-mediated endocytosis of epidermal growth factor by isolated rat hepatocytes. Am. J. Physiol. 260, C457-C467.
128. [128] Sato, H., Terasaki, T., Mizuguchi, H., Okumura, K. and Tsuji, A. (1991) Receptor-recycling model of clearance and distribution of insulin in the perfused mouse liver. Diabetologia 34, 613-621.
129. [129] Linderman, J.J. and Lauffenburger, D.A. (1988) Analysis of intracellular receptor/ligand sorting in endosomes. J. Theor. Biol. 132, 203-245.
130. [130] Linderman, J.J. and Lauffenburger, D.A. (1986) Analysis of intracellular receptor/ligand sorting. Calculation of mean surface and bulk diffusion times within a sphere. Biophys. J. 50, 295-305.
131. [131] Haigler, H.T., Maxfield, F.R., Willingham, M.C. and Pastan, I. (1980) Dansylcadaverine inhibits internalization of 125I-epidermal growth factor in BALB 3T3 cells. J. Biol. Chem. 255, 1239-1241.
132. 125I-insulin by the nonfiltering perfused rat kidney. Biochim. Biophys. Acta 1073, 442-450.
133. [133] Cozza, E.N., Vila, M.C. and Gomez-Sanchez, C.E. (1990) ET-1 receptors in C-6 cells: homologous downregulation and modulation by protein kinase C. Mol. Cell. Endocrinol. 70, 155-164.
134. [134] Eskild, W., Kindberg, G.M., Smedsrod, B., Blomhoff, R., Norum, K.R. and Berg, T. (1989) Intracellular transport of formaldehyde-treated serum albumin in liver endothelial cells after uptake via scavenger receptors. Biochem. J. 258, 511-520.
135. 2. J. Biol. Chem. 261, 4993-4996.
136. [136] Sharma, R.J. and Grant, D.A. (1986) A differential effect between the acute and chronic administration of ethanol on the endocytotic rate constant, ke, for the internalisation of asialoglycoproteins by hepatocytes. Biochim. Biophys. Acta 862, 199-204.
137. [137] Kato, Y. and Sugiyama, Y. (1993) Binding, internalization, degradation, and mitogenic effect of epidermal growth factor in cultured rat hepatocytes. S.T.P. Pharma Sci. 3, 75-82.
138. [138] Decker, S.J. (1990) Epidermal growth factor and transforming growth factor-α induce differential processing of the epidermal growth factor receptor. Biochem. Biophys. Res. Commun. 166, 615-621.
139. [139] Gladhaug, I.P. and Christoffersen, T. (1988) Rapid constitutive internalization and externalization of epidermal growth factor receptors in isolated rat hepatocytes. Monensin inhibits receptor externalization and reduces the capacity for continued endocytosis of epidermal growth factor. J. Biol. Chem. 263, 12199-12203.
140. [140] Presky, D.H. and Schonbrunn, A. (1986) Receptor-bound somatostatin and epidermal growth factor are processed differently in GH4C1 rat pituitary cells. J. Cell Biol. 102, 878-888.
141. [141] Clarke, B.L. and Weigel, P.H. (1985) Recycling of the asialoglycoprotein receptor in isolated rat hepatocytes. ATP depletion blocks receptor recycling but not a single round of endocytosis. J. Biol. Chem. 260, 128-133.
142. [142] Klausner, R.D., Van Renswoude, J., Ashwell, G., Kempf, C., Schechter, A.N., Dean, A. and Bridges, K.R. (1983) Receptor-mediated endocytosis of transferrin in K562 cells. J. Biol. Chem. 258, 4715-4724.
143. [143] Standaert, M.L. and Pollet, R.J. (1984) Equilibrium model for insulin-induced receptor down-regulation. Regulation of insulin receptors in differentiated BC3H-1 myocytes. J. Biol. Chem. 259, 2346-2354.
144. [144] Desbuquois, B., Lopez, S. and Burlet, H. (1982) Ligand-induced translocation of insulin receptors in intact rat liver. J. Biol. Chem. 257, 10852-10860.
145. [145] Frank, H.J., Donohoe, M.T. and Morris, W.L. (1985) Effect of glyburide on in vivo recycling of the hepatic insulin receptor. Am. J. Med. 79, 53-58.
146. [146] Reed, D.K., Newton, C., Fraga, M., Glastad, K., Bagheri, A., Harris, S. and Reed, B.C. (1989) An analysis of the relationship between the cellular distribution and the rate of turnover for the separate classes of unoccupied, noncovalently occupied, and covalently occupied insulin receptor. J. Biol. Chem. 264, 12673-12679.
147. [147] Lai, W.H., Cameron, P.H., Wada, I., Doherty, J.J., Kay, D.G., Posner, B.I. and Bergeron, J.J. (1989) Ligand-mediated internalization, recycling, and downregulation of the epidermal growth factor receptor in vivo. J. Cell Biol. 109, 2741-2749.
148. [148] Liu, K.X., Kato, Y., Narukawa, M., Kim, D.C., Hanano, M., Higuchi, O., Nakamura, T. and Sugiyama, Y. (1992) Importance of the liver in plasma clearance of hepatocyte growth factors in rats. Am. J. Physiol. 263, G642-G649.
149. [149] Sato, H., Sugiyama, Y., Miyauchi, S., Sawada, Y., Iga, T. and Hanano, M. (1986) A simulation study on the effect of a uniform diffusional barrier across hepatocytes on drug metabolism by evenly or unevenly distributed uni-enzyme in the liver. J. Pharm. Sci. 75, 3-8.
150. [150] Logan-Darrough, M. (1995) Pulsatile i.v. insulin therapy for severely out of control diabetes. J. Intrav. Nurs. 18, 124-128.
151. [151] Schmitz, O., Pedersen, S.B., Mengel, A., Porksen, N., Bak, J., Moller, N., Richelsen, B., Alberti, K.G., Butler, P.C. and Orskov, H. (1994) Augmented effect of shortterm pulsatile versus continuous insulin delivery on lipid metabolism but similar effect on whole-body glucose metabolism in obese subjects. Metab. Clin. Exp. 43, 842-846.
152. [152] Paolisso, G., Scheen, A.J., Giugliano, D., Sgambato, S., Albert, A., Varricchio, M., D'Onofrio, F. and Lefebvre, P.J. (1991) Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency. J. Clin. Endocrinol. Metab. 72, 607-615.
153. [153] Bratusch-Marrain, P.R., Komjati, M. and Waldhausl, W.K. (1986) Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in type I diabetic humans. Diabetes 35, 922-926.
154. [154] Matthews, D.R., Naylor, B.A., Jones, R.G., Ward, G.M. and Turner, R.C. (1983) Pulsatile insulin has greater hypoglycemic effect than continuous delivery. Diabetes 32, 617-621.
155. [155] Liu, K.X., Kato, Y., Yamazaki, M., Higuchi, O., Nakamura, T. and Sugiyama, Y. (1993) Decrease in the hepatic clearance of hepatocyte growth factor in carbon tetrachloride-intoxicated rats. Hepatology 17, 651-660.
156. [156] Palomino, E. (1994) "Carobohydrate handles" as natural resources in drug delivery. Adv. Drug Deliv. Rev. 13, 311-323.
157. [157] Casciari, J., Sato, H., Durum, S.K., Fiege, J. and Weinstein, J.N. (1996) Tabular lexicon of cytokine structure and function. In: B.A. Chabner and D. Longo (Eds.), Cancer Chemotherapy: Principles and Practice. Lippincott-Raven Publ., Philadelphia, pp. 785-808.
158. [158] Casciari, J., Sato, H., Durum, S.K., Fiege, J. and Weinstein, J.N. (1996) Reference databases of cytokine structure and function. In: B.A. Chabner (Ed.), Chemotherapy and Biological Response Modifiers Annual, Elsevier, pp. in press.
159. [159] French, A.R., Tadaki, D.K., Niyogi, S.K. and Lauffenburger, D.A. (1995) Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction. J. Biol. Chem. 270, 4334-4340.
160. [160] Davis, C.G., Goldstein, J.L., Sudhof, T.C., Anderson, R.G., Russell, D.W. and Brown, M.S. (1987) Acid-dependent ligand dissociation and recycling of LDL receptor mediated by growth factor homology region. Nature 326, 760-765.
161. [161] D'Souza-Schorey, C., Li, G., Colombo, M.I. and Stahl, P.D. (1995) A regulatory role for ARF6 in receptor-mediated endocytosis. Science 267, 1175-1178.
162. [162] French, A.R., Sudlow, G.P., Wiley, S. and Lauffenburger, D.A. (1994) Postendocytic trafficking of epidermal growth factor-receptor complexes is mediated through saturable and specific endosomal interactions. J. Biol. Chem. 269, 15749-15755.
163. [163] Dintzis, S.M., Velculescu, V.E. and Pfeffers, S.R. (1994) Receptor extracellular domains may contain trafficking information. Studies of the 300-kDa mannose 6-phosphate receptor. J. Biol. Chem. 269, 12159-12166.
164. [164] Perales, J.C., Ferkol, T., Beegen, H., Ratnoff, O.D. and Hanson, R.W. (1994) Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake. Proc. Natl. Acad. Sci. U.S.A. 91, 4086-4090.
165. [165] Chen, J., Stickles, R.J. and Daichendt, K.A. (1994) Galactosylated histone-mediated gene transfer and expression. Hum. Gene Ther. 5, 429-435.
166. [166] Midoux, P., Mendes, C., Legrand, A., Raimond, J., Mayer, R., Monsigny, M. and Roche, A.C. (1993) Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells. Nucl. Acid Res. 21, 871-878.
167. [167] Citro, G., Perrotti, D., Cucco, C., D'Agnano, I., Sacchi, A., Zupi, G. and Calabretta, B. (1992) Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides. Proc. Natl. Acad. Sci. U.S.A. 89, 7031-7035.
168. [168] Wagner, E., Zenke, M., Cotten, M., Beug, H. and Birnstiet, M.L. (1990) Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc. Natl. Acad. Sci. U.S.A. 87, 3410-3414.
169. [169] Zenke, M., Steinlein, P., Wagner, E., Cotten, M., Beug, H. and Birnstiel, M.L. (1990) Receptor-mediated endocytosis of transferrin-polycation conjugates: an efficient way to introduce DNA into hematopoietic cells. Proc. Natl. Acad. Sci. U.S.A. 87, 3655-3659.
170. [170] Chowdhury, N.R., Wu, C.H., Wu, G.Y., Yerneni, P.C., Bommineni, V.R. and Chowdhury, J.R. (1993) Fate of DNA targeted to the liver by asialoglycoprotein receptor-mediated endocytosis in vivo. Prolonged persistence in cytoplasmic vesicles after partial hepatectomy. J. Biol. Chem. 268, 11265-11271.
171. [171] Bunnell, B.A., Askari, F.K. and Wilson, J.M. (1992) Targeted delivery of antisense oligonucleotides by molecular conjugates. Somat. Cell. Mol. Genet. 18, 559-569.
172. [172] Chang, T.M., Hossain, A. and Chang, C.H. (1994) Effect of rate of intracellular transport and diacytosis on cytotoxicity of hybrid toxins. Study with hybrids using hepatic asialoglycoprotein receptor-mediated endocytosis. Biochim. Biophys. Acta 1224, 77-88.
173. [173] Reinis, M., Darnkova, M. and Koree, E. (1993) Receptor-mediated transport of oligodeoxynucleotides into hepatic cells. J. Virol. Methods 42, 99-105.
174. [174] Cristiano, R.J., Smith, L.C., Kay, M.A., Brinkley, B.R. and Woo, S.L. (1993) Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex. Proc. Natl. Acad. Sci. U.S.A. 90, 11548-11552.
175. [175] Bron, R., Ortiz, A. and Wilschut, J. (1994) Cellular cytoplasmic delivery of a polypeptide toxin by reconstituted influenza virus envelopes (virosomes). Biochemistry 33, 9110-9117.
176. [176] Jean, L.F. and Murphy, J.R. (1991) Diphtheria toxin receptor-binding domain substitution with interleukin 6: genetic construction and interleukin 6 receptor-specific action of a diphtheria toxin-related interleukin 6 fusion protein. Prot. Eng. 4, 989-994.
177. [177] Basu, S., Mukhopadhyay, B., Basu, S.K. and Mukhopadhyay, A. (1994) Enhanced intracellular delivery of doxorubicin by scavenger receptor-mediated endocytosis for preferential killing of histiocytic lymphoma cells in culture. FEBS Lett. 342, 249-254.
178. [178] Mukhopadhyay, A. and Basu, S.K. (1990) Enhanced intracellular delivery of methotrexate by a receptor-mediated process. Biotechnol. App. Biochem. 12, 529-536.
179. [179] Samadi-Baboli, M., Favre, G., Canal, P. and Soula, G. (1993) Low density lipoprotein for cytotoxic drug targeting: improved activity of elliptinium derivative against B16 melanoma in mice. Br. J. Cancer 68, 319-326.
180. [180] Lestavel-Delattre, S., Martin-Nizard, F., Clavey, V., Testard, P., Favre, G., Doualin, G., Houssaini, H.S., Bard, J.M., Duriez, P., Delbart, C., et al. (1992) Low-density lipoprotein for delivery of an acrylophenone antineoplastic molecule into malignant cells. Cancer Res. 52, 3629-3635.
181. [181] Nishikawa, M., Kamijo, A., Fujita, T., Takakura, Y., Sezaki, H. and Hashida, M. (1993) Synthesis and pharmacokinetics of a new liver-specific carrier, glycosylated carboxymethyl-dextran, and its application to drug targeting. Pharm. Res. 10, 1253-1261.
182. [182] Molema, G., Jansen, R.W., Pauwels, R., de Clercq, E. and Meijer, D.K. (1990) Targeting of antiviral drugs to T4-lymphocytes. Anti-HIV activity of neoglycoprotein-AZTMP conjugates in vitro. Biochem. Pharmacol. 40, 2603-2610.
183. [183] Midoux, P., Negre, E., Roche, A.C., Mayer, R., Monsigny, M., Balzarini, J., De Clercq, E., Mayer, E., Ghaffar, A. and Gangemi, J.D. (1990) Drug targeting: anti-HSV-1 activity of mannosylated polymer-bound 9-(2-phosphonylmethoxyethyl)adenine. Biochem. Biophys. Res. Commun. 167, 1044-1049.
184. [184] Takakura, Y., Masuda, S., Tokuda, H., Nishikawa, M. and Hashida, M. (1994) Targeted delivery of superoxide dismutase to macrophages via mannose receptor-mediated mechanism. Biochem. Pharmacol. 47, 853-858.
185. [185] Mitsuda, S., Nakagawa, T., Osada, T., Shimamoto, T., Nakazato, H. and Ikai, A. (1993) A receptor mediated delivery of an HIV-1 derived peptide vaccine. Biochem. Biophys. Res. Commun. 194, 1155-1160.
186. [186] Franssen, E.J., Moolenaar, F., de Zeeuw, D. and Meijer, D.K. (1993) Low molecular weight proteins as carriers for renal drug targeting: naproxen coupled to lysozyme via the spacer L-lactic acid. Pharm. Res. 10, 963-969.
187. [187] Zarnegar, R., DeFrances, M.C., Oliver, L. and Michalopoulos, G. (1990) Identification and partial characterization of receptor binding sites for HGF on rat hepatocytes. Biochem. Biophys. Res. Commun. 173, 1179-85.